PATENT CLAIM ANALYSIS

Application Number: 16012992
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["424", "001890"]

Abstract:
Described are assay methods, modules and kits useful in the detection, treatment and/or prevention of dementia and related conditions, including but not limited to Alzheimer's disease and mild cognitive disorders.

Claim (Index 14):
The method of  claim 13  wherein said method further comprises measuring a level of at least one additional biomarker in said two or more test samples, wherein said additional biomarker comprises A\u03b2 16, A\u03b2 17, A\u03b2 42, A\u03b2 40, A\u03b2 38, A\u03b2 39, A\u03b2 37, A\u03b2 34, A\u03b2 43, total tau, P-tau, C-tau, or combinations thereof, and determining from said level(s) of said first biomarker and said level(s) of said at least one additional biomarker the presence and/or absence of plaques in the brain of said patient.

Metadata:
- Claim Count in Document: 31.0
- Percentile: 94.0
- Lexical Diversity: 1.12903
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12867479', '12799484', '13874052', '14200020', '10982545']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7098249208870624
- 35 USC 102 Novelty (BERT): 0.5097687516355278
- Combined Prediction Score: 0.6898193039619089
- Mean Citation Score: 253.80111
- Max Citation Score: 263.87994
- Similarity Product: 198.33330250086303

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test